Global Vaccine Market Growth (Status and Outlook) 2022-2028
As the global economy mends, the 2021 growth of Vaccine will have significant change from previous year. According to our latest study, the global Vaccine market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Vaccine market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Vaccine market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Vaccine market, reaching US$ million by the year 2028. As for the Europe Vaccine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Vaccine players cover AstraZeneca, BioNTech, Boehringer-Ingelheim, and CCBIO, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Vaccine market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Varicella Vaccine
Influenza Vaccine
Polio Vaccine
Hepatitis A Vaccine
Rabies Vaccine
BCG Vaccine
Hepatitis B
Pertussis, Diphtheria, Tetanus
Pneumococcal
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
For Adult
For Child
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
AstraZeneca
BioNTech
Boehringer-Ingelheim
CCBIO
CSL
CureVac
Elanco
GSK
Hulan Bio
Indian Immunologicals
Merck
Minhai Biotechnology
Mitsubishi Tanabe Pharma
Moderna Therapeutics
Mylan
Plumbline Life Sciences
Sanofi
Translate Bio
Walvax Biotechnology
Wuhan Institute of Biological Products
Zoties
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Vaccine Market Size 2017-2028
2.1.2 Vaccine Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Vaccine Segment by Type
2.2.1 Varicella Vaccine
2.2.2 Influenza Vaccine
2.2.3 Polio Vaccine
2.2.4 Hepatitis A Vaccine
2.2.5 Rabies Vaccine
2.2.6 BCG Vaccine
2.2.7 Hepatitis B
2.2.8 Pertussis, Diphtheria, Tetanus
2.2.9 Pneumococcal
2.2.10 Others
2.3 Vaccine Market Size by Type
2.3.1 Vaccine Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Vaccine Market Size Market Share by Type (2017-2022)
2.4 Vaccine Segment by Application
2.4.1 For Adult
2.4.2 For Child
2.5 Vaccine Market Size by Application
2.5.1 Vaccine Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Vaccine Market Size Market Share by Application (2017-2022)
3 Vaccine Market Size by Player
3.1 Vaccine Market Size Market Share by Players
3.1.1 Global Vaccine Revenue by Players (2020-2022)
3.1.2 Global Vaccine Revenue Market Share by Players (2020-2022)
3.2 Global Vaccine Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Vaccine by Regions
4.1 Vaccine Market Size by Regions (2017-2022)
4.2 Americas Vaccine Market Size Growth (2017-2022)
4.3 APAC Vaccine Market Size Growth (2017-2022)
4.4 Europe Vaccine Market Size Growth (2017-2022)
4.5 Middle East & Africa Vaccine Market Size Growth (2017-2022)
5 Americas
5.1 Americas Vaccine Market Size by Country (2017-2022)
5.2 Americas Vaccine Market Size by Type (2017-2022)
5.3 Americas Vaccine Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Vaccine Market Size by Region (2017-2022)
6.2 APAC Vaccine Market Size by Type (2017-2022)
6.3 APAC Vaccine Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Vaccine by Country (2017-2022)
7.2 Europe Vaccine Market Size by Type (2017-2022)
7.3 Europe Vaccine Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Vaccine by Region (2017-2022)
8.2 Middle East & Africa Vaccine Market Size by Type (2017-2022)
8.3 Middle East & Africa Vaccine Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Vaccine Market Forecast
10.1 Global Vaccine Forecast by Regions (2023-2028)
10.1.1 Global Vaccine Forecast by Regions (2023-2028)
10.1.2 Americas Vaccine Forecast
10.1.3 APAC Vaccine Forecast
10.1.4 Europe Vaccine Forecast
10.1.5 Middle East & Africa Vaccine Forecast
10.2 Americas Vaccine Forecast by Country (2023-2028)
10.2.1 United States Vaccine Market Forecast
10.2.2 Canada Vaccine Market Forecast
10.2.3 Mexico Vaccine Market Forecast
10.2.4 Brazil Vaccine Market Forecast
10.3 APAC Vaccine Forecast by Region (2023-2028)
10.3.1 China Vaccine Market Forecast
10.3.2 Japan Vaccine Market Forecast
10.3.3 Korea Vaccine Market Forecast
10.3.4 Southeast Asia Vaccine Market Forecast
10.3.5 India Vaccine Market Forecast
10.3.6 Australia Vaccine Market Forecast
10.4 Europe Vaccine Forecast by Country (2023-2028)
10.4.1 Germany Vaccine Market Forecast
10.4.2 France Vaccine Market Forecast
10.4.3 UK Vaccine Market Forecast
10.4.4 Italy Vaccine Market Forecast
10.4.5 Russia Vaccine Market Forecast
10.5 Middle East & Africa Vaccine Forecast by Region (2023-2028)
10.5.1 Egypt Vaccine Market Forecast
10.5.2 South Africa Vaccine Market Forecast
10.5.3 Israel Vaccine Market Forecast
10.5.4 Turkey Vaccine Market Forecast
10.5.5 GCC Countries Vaccine Market Forecast
10.6 Global Vaccine Forecast by Type (2023-2028)
10.7 Global Vaccine Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 AstraZeneca
11.1.1 AstraZeneca Company Information
11.1.2 AstraZeneca Vaccine Product Offered
11.1.3 AstraZeneca Vaccine Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 AstraZeneca Main Business Overview
11.1.5 AstraZeneca Latest Developments
11.2 BioNTech
11.2.1 BioNTech Company Information
11.2.2 BioNTech Vaccine Product Offered
11.2.3 BioNTech Vaccine Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 BioNTech Main Business Overview
11.2.5 BioNTech Latest Developments
11.3 Boehringer-Ingelheim
11.3.1 Boehringer-Ingelheim Company Information
11.3.2 Boehringer-Ingelheim Vaccine Product Offered
11.3.3 Boehringer-Ingelheim Vaccine Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Boehringer-Ingelheim Main Business Overview
11.3.5 Boehringer-Ingelheim Latest Developments
11.4 CCBIO
11.4.1 CCBIO Company Information
11.4.2 CCBIO Vaccine Product Offered
11.4.3 CCBIO Vaccine Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 CCBIO Main Business Overview
11.4.5 CCBIO Latest Developments
11.5 CSL
11.5.1 CSL Company Information
11.5.2 CSL Vaccine Product Offered
11.5.3 CSL Vaccine Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 CSL Main Business Overview
11.5.5 CSL Latest Developments
11.6 CureVac
11.6.1 CureVac Company Information
11.6.2 CureVac Vaccine Product Offered
11.6.3 CureVac Vaccine Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 CureVac Main Business Overview
11.6.5 CureVac Latest Developments
11.7 Elanco
11.7.1 Elanco Company Information
11.7.2 Elanco Vaccine Product Offered
11.7.3 Elanco Vaccine Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Elanco Main Business Overview
11.7.5 Elanco Latest Developments
11.8 GSK
11.8.1 GSK Company Information
11.8.2 GSK Vaccine Product Offered
11.8.3 GSK Vaccine Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 GSK Main Business Overview
11.8.5 GSK Latest Developments
11.9 Hulan Bio
11.9.1 Hulan Bio Company Information
11.9.2 Hulan Bio Vaccine Product Offered
11.9.3 Hulan Bio Vaccine Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Hulan Bio Main Business Overview
11.9.5 Hulan Bio Latest Developments
11.10 Indian Immunologicals
11.10.1 Indian Immunologicals Company Information
11.10.2 Indian Immunologicals Vaccine Product Offered
11.10.3 Indian Immunologicals Vaccine Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Indian Immunologicals Main Business Overview
11.10.5 Indian Immunologicals Latest Developments
11. Merck
11.11.1 Merck Company Information
11.11.2 Merck Vaccine Product Offered
11.11.3 Merck Vaccine Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Merck Main Business Overview
11.11.5 Merck Latest Developments
11.12 Minhai Biotechnology
11.12.1 Minhai Biotechnology Company Information
11.12.2 Minhai Biotechnology Vaccine Product Offered
11.12.3 Minhai Biotechnology Vaccine Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 Minhai Biotechnology Main Business Overview
11.12.5 Minhai Biotechnology Latest Developments
11.13 Mitsubishi Tanabe Pharma
11.13.1 Mitsubishi Tanabe Pharma Company Information
11.13.2 Mitsubishi Tanabe Pharma Vaccine Product Offered
11.13.3 Mitsubishi Tanabe Pharma Vaccine Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 Mitsubishi Tanabe Pharma Main Business Overview
11.13.5 Mitsubishi Tanabe Pharma Latest Developments
11.14 Moderna Therapeutics
11.14.1 Moderna Therapeutics Company Information
11.14.2 Moderna Therapeutics Vaccine Product Offered
11.14.3 Moderna Therapeutics Vaccine Revenue, Gross Margin and Market Share (2020-2022)
11.14.4 Moderna Therapeutics Main Business Overview
11.14.5 Moderna Therapeutics Latest Developments
11.15 Mylan
11.15.1 Mylan Company Information
11.15.2 Mylan Vaccine Product Offered
11.15.3 Mylan Vaccine Revenue, Gross Margin and Market Share (2020-2022)
11.15.4 Mylan Main Business Overview
11.15.5 Mylan Latest Developments
11.16 Plumbline Life Sciences
11.16.1 Plumbline Life Sciences Company Information
11.16.2 Plumbline Life Sciences Vaccine Product Offered
11.16.3 Plumbline Life Sciences Vaccine Revenue, Gross Margin and Market Share (2020-2022)
11.16.4 Plumbline Life Sciences Main Business Overview
11.16.5 Plumbline Life Sciences Latest Developments
11.17 Sanofi
11.17.1 Sanofi Company Information
11.17.2 Sanofi Vaccine Product Offered
11.17.3 Sanofi Vaccine Revenue, Gross Margin and Market Share (2020-2022)
11.17.4 Sanofi Main Business Overview
11.17.5 Sanofi Latest Developments
11.18 Translate Bio
11.18.1 Translate Bio Company Information
11.18.2 Translate Bio Vaccine Product Offered
11.18.3 Translate Bio Vaccine Revenue, Gross Margin and Market Share (2020-2022)
11.18.4 Translate Bio Main Business Overview
11.18.5 Translate Bio Latest Developments
11.19 Walvax Biotechnology
11.19.1 Walvax Biotechnology Company Information
11.19.2 Walvax Biotechnology Vaccine Product Offered
11.19.3 Walvax Biotechnology Vaccine Revenue, Gross Margin and Market Share (2020-2022)
11.19.4 Walvax Biotechnology Main Business Overview
11.19.5 Walvax Biotechnology Latest Developments
11.20 Wuhan Institute of Biological Products
11.20.1 Wuhan Institute of Biological Products Company Information
11.20.2 Wuhan Institute of Biological Products Vaccine Product Offered
11.20.3 Wuhan Institute of Biological Products Vaccine Revenue, Gross Margin and Market Share (2020-2022)
11.20.4 Wuhan Institute of Biological Products Main Business Overview
11.20.5 Wuhan Institute of Biological Products Latest Developments
11.21 Zoties
11.21.1 Zoties Company Information
11.21.2 Zoties Vaccine Product Offered
11.21.3 Zoties Vaccine Revenue, Gross Margin and Market Share (2020-2022)
11.21.4 Zoties Main Business Overview
11.21.5 Zoties Latest Developments
12 Research Findings and Conclusion
List of Tables
Table 1. Vaccine Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Varicella Vaccine
Table 3. Major Players of Influenza Vaccine
Table 4. Major Players of Polio Vaccine
Table 5. Major Players of Hepatitis A Vaccine
Table 6. Major Players of Rabies Vaccine
Table 7. Major Players of BCG Vaccine
Table 8. Major Players of Hepatitis B
Table 9. Major Players of Pertussis, Diphtheria, Tetanus
Table 10. Major Players of Pneumococcal
Table 11. Major Players of Others
Table 12. Vaccine Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 13. Global Vaccine Market Size by Type (2017-2022) & ($ Millions)
Table 14. Global Vaccine Market Size Market Share by Type (2017-2022)
Table 15. Vaccine Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 16. Global Vaccine Market Size by Application (2017-2022) & ($ Millions)
Table 17. Global Vaccine Market Size Market Share by Application (2017-2022)
Table 18. Global Vaccine Revenue by Players (2020-2022) & ($ Millions)
Table 19. Global Vaccine Revenue Market Share by Player (2020-2022)
Table 20. Vaccine Key Players Head office and Products Offered
Table 21. Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 22. New Products and Potential Entrants
Table 23. Mergers & Acquisitions, Expansion
Table 24. Global Vaccine Market Size by Regions 2017-2022 & ($ Millions)
Table 25. Global Vaccine Market Size Market Share by Regions (2017-2022)
Table 26. Americas Vaccine Market Size by Country (2017-2022) & ($ Millions)
Table 27. Americas Vaccine Market Size Market Share by Country (2017-2022)
Table 28. Americas Vaccine Market Size by Type (2017-2022) & ($ Millions)
Table 29. Americas Vaccine Market Size Market Share by Type (2017-2022)
Table 30. Americas Vaccine Market Size by Application (2017-2022) & ($ Millions)
Table 31. Americas Vaccine Market Size Market Share by Application (2017-2022)
Table 32. APAC Vaccine Market Size by Region (2017-2022) & ($ Millions)
Table 33. APAC Vaccine Market Size Market Share by Region (2017-2022)
Table 34. APAC Vaccine Market Size by Type (2017-2022) & ($ Millions)
Table 35. APAC Vaccine Market Size Market Share by Type (2017-2022)
Table 36. APAC Vaccine Market Size by Application (2017-2022) & ($ Millions)
Table 37. APAC Vaccine Market Size Market Share by Application (2017-2022)
Table 38. Europe Vaccine Market Size by Country (2017-2022) & ($ Millions)
Table 39. Europe Vaccine Market Size Market Share by Country (2017-2022)
Table 40. Europe Vaccine Market Size by Type (2017-2022) & ($ Millions)
Table 41. Europe Vaccine Market Size Market Share by Type (2017-2022)
Table 42. Europe Vaccine Market Size by Application (2017-2022) & ($ Millions)
Table 43. Europe Vaccine Market Size Market Share by Application (2017-2022)
Table 44. Middle East & Africa Vaccine Market Size by Region (2017-2022) & ($ Millions)
Table 45. Middle East & Africa Vaccine Market Size Market Share by Region (2017-2022)
Table 46. Middle East & Africa Vaccine Market Size by Type (2017-2022) & ($ Millions)
Table 47. Middle East & Africa Vaccine Market Size Market Share by Type (2017-2022)
Table 48. Middle East & Africa Vaccine Market Size by Application (2017-2022) & ($ Millions)
Table 49. Middle East & Africa Vaccine Market Size Market Share by Application (2017-2022)
Table 50. Key Market Drivers & Growth Opportunities of Vaccine
Table 51. Key Market Challenges & Risks of Vaccine
Table 52. Key Industry Trends of Vaccine
Table 53. Global Vaccine Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 54. Global Vaccine Market Size Market Share Forecast by Regions (2023-2028)
Table 55. Global Vaccine Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 56. Global Vaccine Market Size Market Share Forecast by Type (2023-2028)
Table 57. Global Vaccine Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 58. Global Vaccine Market Size Market Share Forecast by Application (2023-2028)
Table 59. AstraZeneca Details, Company Type, Vaccine Area Served and Its Competitors
Table 60. AstraZeneca Vaccine Product Offered
Table 61. AstraZeneca Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 62. AstraZeneca Main Business
Table 63. AstraZeneca Latest Developments
Table 64. BioNTech Details, Company Type, Vaccine Area Served and Its Competitors
Table 65. BioNTech Vaccine Product Offered
Table 66. BioNTech Main Business
Table 67. BioNTech Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 68. BioNTech Latest Developments
Table 69. Boehringer-Ingelheim Details, Company Type, Vaccine Area Served and Its Competitors
Table 70. Boehringer-Ingelheim Vaccine Product Offered
Table 71. Boehringer-Ingelheim Main Business
Table 72. Boehringer-Ingelheim Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 73. Boehringer-Ingelheim Latest Developments
Table 74. CCBIO Details, Company Type, Vaccine Area Served and Its Competitors
Table 75. CCBIO Vaccine Product Offered
Table 76. CCBIO Main Business
Table 77. CCBIO Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 78. CCBIO Latest Developments
Table 79. CSL Details, Company Type, Vaccine Area Served and Its Competitors
Table 80. CSL Vaccine Product Offered
Table 81. CSL Main Business
Table 82. CSL Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 83. CSL Latest Developments
Table 84. CureVac Details, Company Type, Vaccine Area Served and Its Competitors
Table 85. CureVac Vaccine Product Offered
Table 86. CureVac Main Business
Table 87. CureVac Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 88. CureVac Latest Developments
Table 89. Elanco Details, Company Type, Vaccine Area Served and Its Competitors
Table 90. Elanco Vaccine Product Offered
Table 91. Elanco Main Business
Table 92. Elanco Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 93. Elanco Latest Developments
Table 94. GSK Details, Company Type, Vaccine Area Served and Its Competitors
Table 95. GSK Vaccine Product Offered
Table 96. GSK Main Business
Table 97. GSK Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 98. GSK Latest Developments
Table 99. Hulan Bio Details, Company Type, Vaccine Area Served and Its Competitors
Table 100. Hulan Bio Vaccine Product Offered
Table 101. Hulan Bio Main Business
Table 102. Hulan Bio Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 103. Hulan Bio Latest Developments
Table 104. Indian Immunologicals Details, Company Type, Vaccine Area Served and Its Competitors
Table 105. Indian Immunologicals Vaccine Product Offered
Table 106. Indian Immunologicals Main Business
Table 107. Indian Immunologicals Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 108. Indian Immunologicals Latest Developments
Table 109. Merck Details, Company Type, Vaccine Area Served and Its Competitors
Table 110. Merck Vaccine Product Offered
Table 111. Merck Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 112. Merck Main Business
Table 113. Merck Latest Developments
Table 114. Minhai Biotechnology Details, Company Type, Vaccine Area Served and Its Competitors
Table 115. Minhai Biotechnology Vaccine Product Offered
Table 116. Minhai Biotechnology Main Business
Table 117. Minhai Biotechnology Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 118. Minhai Biotechnology Latest Developments
Table 119. Mitsubishi Tanabe Pharma Details, Company Type, Vaccine Area Served and Its Competitors
Table 120. Mitsubishi Tanabe Pharma Vaccine Product Offered
Table 121. Mitsubishi Tanabe Pharma Main Business
Table 122. Mitsubishi Tanabe Pharma Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 123. Mitsubishi Tanabe Pharma Latest Developments
Table 124. Moderna Therapeutics Details, Company Type, Vaccine Area Served and Its Competitors
Table 125. Moderna Therapeutics Vaccine Product Offered
Table 126. Moderna Therapeutics Main Business
Table 127. Moderna Therapeutics Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 128. Moderna Therapeutics Latest Developments
Table 129. Mylan Details, Company Type, Vaccine Area Served and Its Competitors
Table 130. Mylan Vaccine Product Offered
Table 131. Mylan Main Business
Table 132. Mylan Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 133. Mylan Latest Developments
Table 134. Plumbline Life Sciences Details, Company Type, Vaccine Area Served and Its Competitors
Table 135. Plumbline Life Sciences Vaccine Product Offered
Table 136. Plumbline Life Sciences Main Business
Table 137. Plumbline Life Sciences Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 138. Plumbline Life Sciences Latest Developments
Table 139. Sanofi Details, Company Type, Vaccine Area Served and Its Competitors
Table 140. Sanofi Vaccine Product Offered
Table 141. Sanofi Main Business
Table 142. Sanofi Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 143. Sanofi Latest Developments
Table 144. Translate Bio Details, Company Type, Vaccine Area Served and Its Competitors
Table 145. Translate Bio Vaccine Product Offered
Table 146. Translate Bio Main Business
Table 147. Translate Bio Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 148. Translate Bio Latest Developments
Table 149. Walvax Biotechnology Details, Company Type, Vaccine Area Served and Its Competitors
Table 150. Walvax Biotechnology Vaccine Product Offered
Table 151. Walvax Biotechnology Main Business
Table 152. Walvax Biotechnology Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 153. Walvax Biotechnology Latest Developments
Table 154. Wuhan Institute of Biological Products Details, Company Type, Vaccine Area Served and Its Competitors
Table 155. Wuhan Institute of Biological Products Vaccine Product Offered
Table 156. Wuhan Institute of Biological Products Main Business
Table 157. Wuhan Institute of Biological Products Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 158. Wuhan Institute of Biological Products Latest Developments
Table 159. Zoties Details, Company Type, Vaccine Area Served and Its Competitors
Table 160. Zoties Vaccine Product Offered
Table 161. Zoties Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 162. Zoties Main Business
Table 163. Zoties Latest Developments
List of Figures
Figure 1. Vaccine Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Vaccine Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Vaccine Market Size Market Share by Type in 2021
Figure 7. Vaccine in For Adult
Figure 8. Global Vaccine Market: For Adult (2017-2022) & ($ Millions)
Figure 9. Vaccine in For Child
Figure 10. Global Vaccine Market: For Child (2017-2022) & ($ Millions)
Figure 11. Global Vaccine Market Size Market Share by Application in 2021
Figure 12. Global Vaccine Revenue Market Share by Player in 2021
Figure 13. Global Vaccine Market Size Market Share by Regions (2017-2022)
Figure 14. Americas Vaccine Market Size 2017-2022 ($ Millions)
Figure 15. APAC Vaccine Market Size 2017-2022 ($ Millions)
Figure 16. Europe Vaccine Market Size 2017-2022 ($ Millions)
Figure 17. Middle East & Africa Vaccine Market Size 2017-2022 ($ Millions)
Figure 18. Americas Vaccine Value Market Share by Country in 2021
Figure 19. Americas Vaccine Consumption Market Share by Type in 2021
Figure 20. Americas Vaccine Market Size Market Share by Application in 2021
Figure 21. United States Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 22. Canada Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 23. Mexico Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 24. Brazil Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 25. APAC Vaccine Market Size Market Share by Region in 2021
Figure 26. APAC Vaccine Market Size Market Share by Application in 2021
Figure 27. China Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 28. Japan Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 29. Korea Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 30. Southeast Asia Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 31. India Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 32. Australia Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 33. Europe Vaccine Market Size Market Share by Country in 2021
Figure 34. Europe Vaccine Market Size Market Share by Type in 2021
Figure 35. Europe Vaccine Market Size Market Share by Application in 2021
Figure 36. Germany Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 37. France Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 38. UK Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 39. Italy Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 40. Russia Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 41. Middle East & Africa Vaccine Market Size Market Share by Region in 2021
Figure 42. Middle East & Africa Vaccine Market Size Market Share by Type in 2021
Figure 43. Middle East & Africa Vaccine Market Size Market Share by Application in 2021
Figure 44. Egypt Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 45. South Africa Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 46. Israel Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 47. Turkey Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 48. GCC Country Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 49. Americas Vaccine Market Size 2023-2028 ($ Millions)
Figure 50. APAC Vaccine Market Size 2023-2028 ($ Millions)
Figure 51. Europe Vaccine Market Size 2023-2028 ($ Millions)
Figure 52. Middle East & Africa Vaccine Market Size 2023-2028 ($ Millions)
Figure 53. United States Vaccine Market Size 2023-2028 ($ Millions)
Figure 54. Canada Vaccine Market Size 2023-2028 ($ Millions)
Figure 55. Mexico Vaccine Market Size 2023-2028 ($ Millions)
Figure 56. Brazil Vaccine Market Size 2023-2028 ($ Millions)
Figure 57. China Vaccine Market Size 2023-2028 ($ Millions)
Figure 58. Japan Vaccine Market Size 2023-2028 ($ Millions)
Figure 59. Korea Vaccine Market Size 2023-2028 ($ Millions)
Figure 60. Southeast Asia Vaccine Market Size 2023-2028 ($ Millions)
Figure 61. India Vaccine Market Size 2023-2028 ($ Millions)
Figure 62. Australia Vaccine Market Size 2023-2028 ($ Millions)
Figure 63. Germany Vaccine Market Size 2023-2028 ($ Millions)
Figure 64. France Vaccine Market Size 2023-2028 ($ Millions)
Figure 65. UK Vaccine Market Size 2023-2028 ($ Millions)
Figure 66. Italy Vaccine Market Size 2023-2028 ($ Millions)
Figure 67. Russia Vaccine Market Size 2023-2028 ($ Millions)
Figure 68. Spain Vaccine Market Size 2023-2028 ($ Millions)
Figure 69. Egypt Vaccine Market Size 2023-2028 ($ Millions)
Figure 70. South Africa Vaccine Market Size 2023-2028 ($ Millions)
Figure 71. Israel Vaccine Market Size 2023-2028 ($ Millions)
Figure 72. Turkey Vaccine Market Size 2023-2028 ($ Millions)
Figure 73. GCC Countries Vaccine Market Size 2023-2028 ($ Millions)
